. home.aspx

NEWS

home.aspx
   


U.S. regulator says too many drugmakers chasing same cancer strategy

June 10, 2016 /
SHARESHARESHARE

CHICAGO: A new type of cancer drug that takes the brakes off the body's immune system has given drugmakers some remarkable wins against the deadly disease, but a top U.S. regulator says too many companies are focused on the same approach…